510(k) Report

510(k) · Cleared

Recalled · 2003

Axsym Free Thyroxine ( Free T4 )

K934544510(k) TraditionalCleared Jun 21, 1994272-day reviewClass II21 CFR 862.1695Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · CEC Radioimmunoassay, Free Thyroxine

Cleared on Jun 21, 1994 after a 272-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Jun 21, 1994
Review
272 days
Class
Class II
Product code
CEC
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K934544Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CEC device

  1. #1 K240273 Access Free T4score 7.0 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 30, 2003Not classifiedZ-1130-03OtherThe Free T4 Controls, may yield control values that are high and outside of the package insert ranges.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CEC devices

CEC Radioimmunoassay, Free Thyroxine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CEC

1in 2024

2007: 12008: 22009: 12012: 12013: 22014: 32015: 12016: 12017: 12018: 22023: 12024: 1
2007high 3 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CEC

238in 2014

2014: 238 days median
2007high 238 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CEC

1in 2018

2010: 32013: 12018: 1
2007high 3 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEC

213in 2025

2009: 22010: 72011: 152012: 62013: 62014: 402015: 1662016: 1482017: 1962018: 1992019: 1672020: 1062021: 962022: 812023: 992024: 2762025: 213
2007high 276 (2024) · low 0 (2007)2025

MAUDE reports naming product code CEC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20091—02
20100—37
20110—015
20121—06
20132—16
20143238040
20151—0166
20161—0148
20171—0196
20182—1199
20190—0167
20200—0106
20210—096
20220—081
20231—099
20241—0276
20250—0213
20260—0—
Cite this page

510(k) Report. “K934544: Axsym Free Thyroxine ( Free T4 ).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K934544

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026